S. Ngiow

Immunology · 2015–2020

A researcher in the Science corpus: 5 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom S. Ngiow trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Pardoll
  2. Guido Kroemer
  3. Daniel S. Chen
  4. Janis Taube

Papers from S. Ngiow's perspective

Ordered by how strongly the researchers S. Ngiow trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  2. Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape (Science Translational Medicine)
  3. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer (Nature)
  4. Immunogenic cell death in cancer therapy. (Annual Review of Immunology)
  5. Intratumoral Tcf1+PD‐1+CD8+ T Cells with Stem‐like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy (Immunity)
  6. A Single Dose of Neoadjuvant PD-1 Blockade Predicts Clinical Outcomes in Resectable Melanoma (Nature Medicine)
  7. Molecular Pathways: Next-Generation Immunotherapy—Inhibiting Programmed Death-Ligand 1 and Programmed Death-1 (Clinical Cancer Research)
  8. T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections. (Immunity)
  9. svaseq: removing batch effects and other unwanted noise from sequencing data (bioRxiv)
  10. Intravascular staining for discrimination of vascular and tissue leukocytes (Nature Protocols)

Their papers